American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Huazhu Hotels Group
HTHT
$12.5B
| $12.6M | 0.01% |
330,122
+285,751
| +644% | +$8.95M |
|
827
Bread Financial
BFH
$4.51B
| $12.5M | 0.01% |
337,445
+122,093
| +57% | +$6.22M |
|
828
Insmed
INSM
$27.6B
| $12.5M | 0.01% |
632,001
+42,844
| +7% | +$898K |
|
829
Dow Inc
DOW
$21.9B
| $12.4M | 0.01% |
241,106
+75,942
| +46% | +$4.86M |
|
830
NetEase
NTES
$78.5B
| $12.4M | 0.01% |
133,084
+22,251
| +20% | +$2.12M |
|
831
iShares Russell 1000 Growth ETF
IWF
$129B
| $12.4M | 0.01% |
226,640
+29,572
| +15% | +$1.78M |
|
832
Lam Research
LRCX
$422B
| $12.3M | 0.01% |
289,060
+48,860
| +20% | +$2.33M |
|
833
Diodes
DIOD
$4.48B
| $12.3M | 0.01% |
190,233
+75,330
| +66% | +$5.49M |
|
|
VRTV
834
DELISTED
VERITIV CORPORATION
VRTV
| $12.3M | 0.01% |
112,890
+38,097
| +51% | +$5.19M |
|
835
NiSource
NI
$20.2B
| $12.2M | 0.01% |
414,787
-13,925
| -3% | -$422K |
|
836
Ironwood Pharmaceuticals
IRWD
$674M
| $12.2M | 0.01% |
1,058,120
+398,840
| +60% | +$4.7M |
|
837
FTI Consulting
FCN
$4.24B
| $12.2M | 0.01% |
+67,277
| New | +$11.1M |
|
838
Telephone and Data Systems
TDS
$4.03B
| $12.2M | 0.01% |
769,941
+184,258
| +31% | +$3.29M |
|
839
Grocery Outlet
GO
$1.07B
| $12.2M | 0.01% |
285,111
-246,904
| -46% | -$9.02M |
|
840
Allegiant Air
ALGT
$2.36B
| $12.1M | 0.01% |
107,155
+42,852
| +67% | +$6.17M |
|
|
GBT
841
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $12.1M | 0.01% |
377,862
+25,527
| +7% | +$747K |
|
|
SBDS
842
DELISTED
Solo Brands Inc
SBDS
| $12.1M | 0.01% |
74,296
+20,659
| +39% | +$4.51M |
|
843
Arcutis Biotherapeutics
ARQT
$3.25B
| $12M | 0.01% |
564,644
+40,085
| +8% | +$822K |
|
844
Descartes Systems
DSGX
$6.62B
| $11.9M | 0.01% |
192,281
+705
| +0.4% | +$44K |
|
|
TWKS
845
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $11.9M | 0.01% |
845,371
+57,505
| +7% | +$995K |
|
846
Fox Factory Holding Corp
FOXF
$886M
| $11.9M | 0.01% |
148,084
+10,056
| +7% | +$847K |
|
847
CSX Corp
CSX
$92.9B
| $11.9M | 0.01% |
409,937
+108,502
| +36% | +$3.54M |
|
848
Associated Banc-Corp
ASB
$6.07B
| $11.9M | 0.01% |
652,055
+159,636
| +32% | +$3.23M |
|
|
SFBS
849
ServisFirst Bancshares
SFBS
$5B
| $11.8M | 0.01% |
149,114
-7,961
| -5% | -$648K |
|
|
VRN
850
DELISTED
Veren
VRN
| $11.7M | 0.01% |
1,647,705
+298,479
| +22% | +$2.34M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.